登录 | 注册    关注公众号  
搜索
 > 【ROR2】

ROR2信息

英文名称:Tyrosine-protein kinase transmembrane receptor ROR2
中文名称:蛋白酪氨酸激酶跨膜受体ROR2
靶点别称:EC:2.7.10.1,ROR2,NTRKR2,Receptor Tyrosine Kinase Like Orphan Receptor 2,Tyrosine-Protein Kinase Transmembrane Receptor ROR2,Neurotrophic Tyrosine Kinase, Receptor-Related 2,Neurotrophic Tyrosine Kinase Receptor-Related 2,Receptor Tyrosine Kinase-Like Orphan Receptor 2,EC 2.7.10.1,BDB1,BDB
上市药物数量:0
临床药物数量:1
最高研发阶段:临床二期

ROR2产品列表

 
评论(1)
RO2-H52E5|Human ROR2 / NTRKR2 Protein, His Tag
  1. 153XXXXXXX5
  2. 0人赞
  3. 使用这款同家族蛋白,Human ROR2-His(RO2-H52E5),用途是基于ELISA的同家族蛋白的区分,在小鼠血清效价检测与杂交瘤上清阶段,都可以用这个蛋白来表征抗体库的性质。
  4. 2022-06-05
 

ROR2 分子别名

ROR2,NTRKR2

ROR2 分子背景

Tyrosine-protein kinase transmembrane receptor ROR2 is also known as Neurotrophic tyrosine kinase, receptor-related 2 (NTRKR2), which belongs to the protein kinase superfamily and Tyr protein kinase family and ROR subfamily. ROR2 is a homodimer protein, which can binds YWHAB or interact with WTIP. ROR2 may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development.

ROR2 前沿进展

ROR2临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
CCT301-59 CCT301-59 F1 Oncology, Bioatla 详情
Ozuriftamab Vedotin CAB-ROR2-ADC; CAB-ADC; CAB-ROR2; BA-3021; HTBA-3021 临床二期 Bioatla 实体瘤, 头颈癌, 卵巢癌, 头颈部鳞状细胞癌, 三阴性乳腺肿瘤, 黑色素瘤, 非小细胞肺癌, 转移癌 详情

消息提示

请输入您的联系方式,再点击提交!

确定